Company News Market Information

Market Information Sharing 3.27

Mar. 27, 2019

Dear Arshine Customers,

 

Many thanks for your interests in our market information sharing! In API market, affected by the explosion event occurred in a chemical plant in Yancheng, Jiangsu province, China, the mfgs began safety inspections. The mfgs of Ciprofloxacin hcl and Enrofloxacin hcl stop offering price. In vitamin market, the mfgs of VB1 and VB6 stop offering price, and the market price are rising.

 

Based on the principle of “Earnest and sincere cooperation, and win-win future”, we Arshine Pharma would like to share the changes of China's domestic APIs to our valued customers. And the market and industry information will be shared from time to time.

 

Thank you for reading this market information & continuous support to Arshine sincerely. And we also hope that you can purchase the goods from Arshine with good support & service!

 

We wish you a smooth work and prosperous business.

 

Arshine Pharmaceutical Co., Ltd.

Wednesday, Mar. 27th, 2019

Disclaimer

The report data is for reference only since it is made just based on China domestic information with limited sources, without specific economic activities guidance.

 

This report shall not be reproduced with our permission.

This information is forbidden for external transmission. If there is violation, it will be discontinued to be shared. Thank you for your cooperation.



Section One Antibiotics

CategoryTypeRepresentative productsAnalyses of market conditionWeekly trend
AntibioticsSulfonamidesSulfadiazine, Sulfadimidine, etc.Parts of products price is increasing strongly. The current tight supply ease for a short time but the price is firming and delivery of continuously tight.Rising
QuinolonesCiprofloxacin hcl, Enrofloxacin, levofloxacin, etc.Affected by the explosion event occurred in a chemical plant in Yancheng, the mfgs began a safety inspections and even maybe shutdown.Rising
TetracyclinesOxytetracycline hcl, Doxycycline hyclate, etc.The price of oxytetracycline base is rising.The price of oxytetracycline hydrochloride is rising with tight supply.For doxycycline hyclate ,the price is rising too, and it is limited supply in the market.Rising
PenicillinsAmoxicillin, ampicillin, penicillin V potassium, etc.Due to the price increase of side chain, the price of amoxicillin and ampicillin are rising with tight supply.Rising
CephalosporinsCefradine, cefalexin, cefadroxil, etc.The price Cefradine is decreasing with normal supply. The  price of cephalexin is stable with tight supply. The price for 7-ACA is stable, ceftriaxone sodium and cefotaxime sodium is decreasing slightly. Other series products price is decreasing from high level such as Cefuroxime sodium, cefoperazone sodium/sulbactam sodium, cefepime arginine, ceftazidime sodium carbonate. Cefazolin sodium and Ceftizoxime sodium is in serious shortage and their price still at a high level. Cefalexin’s supply is a little tense now due to lots order from domestic market.Decreasing slowly
AmphenicolsChloramphenicol, florfenicolStable marketStable
MacrolidesErythromycin thiocyanate, azithromycinThe price of Erythromycin thiocyanate is stable while Azithromycin is decreasing slightly due to weak market demand.Stable
Tylosin tartrate granular and powderTilmicosin phosphate.Price is table, but the supply is tight, delivery time for new orders need to check twice..Relative stable
LincosamidesLincomycin, clindamycinMarket is down, price and supply are stable.stable
AminoglycosidesStreptomycin/dihydrostreptomycin, neomycin sulphate, gentamycin, spectinomycin, etc.Streptomycin/dihydrostreptomycin/ normal supply, stable price. Neomycin: supply back to normal now,we predict market will down .Gentamicin: major Mfgs stopped offering suddenly ,it’s said price may will increase.Spectinomycin: normal supply, and the market fell slightly.Relative stable



Section Two Vermifuges

CategoryTypeRepresentative productsAnalyses of market conditionWeekly trend
VermifugesNematode-repellent drugsBenzimidazolesAlbendazole, fenbendazole, oxfendazole, flubendazole, etc.Albendazole: The mfgs put back on production in succession, the output in the early stage is small, and the market continued to be bullish and delivery need wait 1-2 month.Fenbendazole: The price is stable;Oxybendazole: At present, it is in tight supply since the mfg has insufficient raw materials, and its price is risingRising
BenzothiazolesLevamisole, etc.Stable market, normal supply.Stable
TetrahydropyrimidinePyrantel pamoate, etc.Stable market, normal supply. The price from India have an advantageStable
AntibioticsIvermectin, avermectin, moxidectin, etc.The supply of Avermectin is not as tight as it before.For Ivermectin, the outlook of market is decreasing.Stable
Anti-tapeworm drugIsoquinolinePraziquantel, epsiprantel, etc.Stable market, normal supply.Stable
Anticoccidial drugQuinolinesDecoquinateStable market, normal supply.Stable
TriazinesDiclazuril, toltrazuril, etcStable market, the supply of toltrazuril is tight.Stable
Pyridines and othersClopidol , amprolium, etcClopidol: Stable market, normal supply.The supply of Amprolium is so tight.Rising


Section Three Vitamins

CategoryProductsAnalyses of market conditionWeekly trend
VitaminsVB1Mfgs stop offering price, and the market price is rising.Rising
VB2B2 (98%): The market is stable and the price is running at a high level.B2 (80%): market is down.Stable
VB3The price is stable this week after the price increase.Stable
VB5All of the mfgs stop offering price, and the market price is rising.Rising
VB6Mfgs stop offering price, and the market price is rising.Rising
VB9Rising cost of raw material, its supply is so tight with increasing price, the market attention has increased, and the market price of Folic acid rises slightly.Rising
VB12Volatile markets and the price is stable in short term.Stable
VCWeak demand, weak price.Decreasing
VAMfgs resumed the quotation with declining.Decreasing
VEMfgs stop offering price,price is increasingRising

VH(VB7)Its back to stable level now.Stable

VK3 The price is stable after the price increasing.Stable


This report shall not be reproduced with our permission.

This information is forbidden for external transmission. If there is violation, it will be discontinued to be shared. Thank you for your cooperation.